Hematology

A second course of R CHOP achieved durable responses in late relapse diffuse large B cell lymphoma, especially in patients relapsing more than 5 years after diagnosis.

Biologically informed plasma p-tau217 cutoffs improve amyloid beta detection accuracy and cost efficiency, outperforming standard thresholds and highlighting subgroup specific strategies for clinical implementation.

Early morning cord blood transplantation was shown to reduce acute graft-versus-host disease severity and improve survival.

A personalised multipeptide T cell activator induced durable immune responses and showed an acceptable safety profile in patients with chronic lymphocytic leukaemia in a phase one trial.

Presented at EAHAD 2026 and awarded third best poster, this multicentre study demonstrates that product-specific calibration improves the accuracy of factor VIII activity measurement across assay platforms.

Early initiation of prophylaxis before 20 years of age protects against bone loss in haemophilia, while delayed or absent treatment is linked to significantly higher osteoporosis risk.

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

A nursing-led remote evaluation enabled earlier prioritisation and improved multidisciplinary assessment for adolescents referred with heavy menstrual bleeding.